GlycoTherapeutics
PrivateLast Round
Grant
Jul 10, 2025
Total Funding Raised
$2.37M
Company Overview
GlycoTherapeutics is a biotechnology company that develops anticancer drugs targeting glycans to overcome efficacy limitations in cancer immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlycoTherapeutics Comparables
Compare GlycoTherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Valora Therapeutics Inc. | 84% | |
| Tacalyx | 83% | |
| Adaptam Therapeutics | 81% |
GlycoTherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 10, 2025 | ||||
| Grant | Apr 26, 2023 | ||||
| Grant | Feb 14, 2023 | ||||
| Grant | Jan 1, 2022 |
GlycoTherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Province of Gelderland | Grant |
| KWF Dutch Cancer Society | Grant |
| Radboud University | Pre Seed |
| The Launch | Pre Seed |
| Netherlands Organization for Scientific Research | Grant |
| Oost NL | Pre Seed, Grant |
| East Netherlands Development Agency (Oost NL) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
Grew 200% QoQ, from 2 to 6 employees.
- Jul 10, 2025
Received grant funding to support operations.
GlycoTherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access